Pharma’s Upcoming Messaging Battles In US Pricing Debate Foreshadowed In CBO Report

 
• By Sarah Karlin-Smith
Pills in Capitol Hill forecast
The CBO report probably won't change the forecast for Rx pricing legislation, but it will definitely hang in the air.

More from Pricing Debate

More from Market Access